Bicocca Open Archive

Logo unimib boa
BANDERA, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.870
EU - Europa 1.428
AS - Asia 683
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 6
SA - Sud America 6
OC - Oceania 5
Totale 5.005
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.788
IE - Irlanda 258
CN - Cina 254
SG - Singapore 251
IT - Italia 235
SE - Svezia 230
DE - Germania 221
RU - Federazione Russa 142
UA - Ucraina 97
HK - Hong Kong 78
CA - Canada 72
GB - Regno Unito 70
DK - Danimarca 54
FI - Finlandia 46
VN - Vietnam 24
ID - Indonesia 21
TR - Turchia 17
IN - India 15
AT - Austria 12
BE - Belgio 12
FR - Francia 11
NL - Olanda 11
PL - Polonia 9
IR - Iran 7
EU - Europa 5
HN - Honduras 5
AU - Australia 4
BZ - Belize 4
CZ - Repubblica Ceca 4
BR - Brasile 3
CH - Svizzera 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
EG - Egitto 2
ES - Italia 2
JP - Giappone 2
KR - Corea 2
ML - Mali 2
PT - Portogallo 2
RO - Romania 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
BS - Bahamas 1
CL - Cile 1
EE - Estonia 1
IL - Israele 1
KH - Cambogia 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
SI - Slovenia 1
TH - Thailandia 1
Totale 5.005
Salva come PNG Salva come JPEG
Città #
Ann Arbor 375
Fairfield 276
Chandler 271
Dublin 253
Singapore 213
Woodbridge 186
Houston 185
Wilmington 169
Frankfurt am Main 158
Ashburn 122
New York 113
Jacksonville 100
Seattle 99
Dearborn 96
Cambridge 94
Hong Kong 76
Princeton 71
Milan 70
Santa Clara 59
Shanghai 46
Nanjing 41
Lawrence 32
Altamura 31
Ottawa 28
Helsinki 25
Beijing 21
Fremont 21
Los Angeles 20
Florence 19
Lachine 19
Nanchang 19
San Diego 19
Dong Ket 18
Jakarta 18
Buffalo 13
Andover 12
Brussels 12
Edmonton 12
London 12
Shenyang 12
Munich 11
Hebei 10
Kunming 9
Boardman 8
Guangzhou 8
Hangzhou 8
Kiev 8
Toronto 8
Vienna 8
Changsha 7
Falls Church 7
Jinan 7
Norwalk 7
Tianjin 7
Zhengzhou 7
Amsterdam 6
Pune 6
Romola 6
Hanoi 5
Tegucigalpa 5
Belize City 4
Enterprise 4
Nuremberg 4
Piacenza 4
Polska 4
San Francisco 4
Taizhou 4
Casper 3
Clearwater 3
Columbus 3
Darlington 3
Detroit 3
Edinburgh 3
Kilburn 3
Melzo 3
Ningbo 3
Rome 3
Semarang 3
São Paulo 3
Acton 2
Ancona 2
Aversa 2
Bamako 2
Berlin 2
Brno 2
Buenos Aires 2
Carate Brianza 2
Chicago 2
Dallas 2
Delhi 2
Foshan 2
Grassobbio 2
Groningen 2
Jiaxing 2
Lanzhou 2
Lisbon 2
Loreto 2
Miami 2
Montecchio Maggiore 2
Redmond 2
Totale 3.690
Salva come PNG Salva come JPEG
Nome #
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 234
Effects of autologous stem cell transplantation in HIV: searching for the origins of viral replication in settings of profound CD4(+) T cell depletion 225
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 218
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 212
Microbiota in ICU, not only a gut problem 211
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 185
Brachial and central blood pressure in HIV-infected subjects 180
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: Results of the "cOPA" pilot randomized trial 178
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 177
Impact of orotracheal intubation and mechanical ventilation on the microbiota of the lung in the development of Ventilator- Associated Pneumonia 177
Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated with the Evolution of Cognitive Performance in HIV-Infected Patients 176
ECMO: An alternative support for acute respiratory failure caused by tuberculosis? 174
Unmasking tuberculosis in the era of antiretroviral treatment 167
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 165
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 165
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 164
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 163
Use of CXCR4-antagonist for haematopoietic stem cell mobilization in HIV-infected patients with haematological malignancies 159
Strategies to limit immune-activation in HIV patients 158
Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals 145
Characterization of immune failure by monocyte activation phenotypes in HIV-infected patients receiving antiretroviral therapy 144
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 136
Combination antifungal therapy for invasive mold infections among pediatric patients with hematological malignancies: Data from a real-life case-series 134
Exogenous reinfection of tuberculosis in a low-burden area 111
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 84
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 79
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 73
Arterial structural and functional effects of two different antiretroviral therapy protocol on naïve HIV-infected subjects 72
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study 72
Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study 72
Early changes in adhesion molecules expression and endothelial function in patients initiating ART with Atazanavir or Lopinavir 71
Unmasked tuberculosis or lymphoma in late AIDS presenters: A difficult differential diagnosis 69
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 65
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 63
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 59
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir 57
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 54
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 52
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study 51
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 48
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 45
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858) 45
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 34
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 34
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 19
Plasma, Intracellular and Lymph Node Antiretroviral Concentrations and HIV DNA Change During Primary HIV Infection: Results from the INACTION P25 Study 18
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 18
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 3
Totale 5.415
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.885
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020482 0 0 0 0 0 0 108 75 108 88 81 22
2020/2021510 35 48 60 48 31 49 40 55 47 37 21 39
2021/2022474 15 21 46 60 20 48 21 36 23 55 29 100
2022/2023959 102 316 74 113 40 129 10 68 65 8 23 11
2023/2024754 19 14 46 32 92 217 144 37 52 23 6 72
2024/2025709 88 181 125 90 147 78 0 0 0 0 0 0
Totale 5.415